MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Hand and Arm Function in Persons with De Novo Parkinson’s Disease

    B. Lindholm, LB. Dahlin, CH. Brogårdh, E. Franzen (Malmö, Sweden)

    Objective: To evaluate hand and arm function and its association with motor symptoms as well as activities of daily living (ADL) in de novo Parkinson's…
  • 2024 International Congress

    The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor

    A. Dave, J. Frey, J. Yu, J. Lopes, C. Hess (Plainsboro, USA)

    Objective: To examine how Deep Brain Stimulation (DBS) influences embarrassment and self-esteem in patients with essential tremor (ET) and assess caregiver impressions. Background: Social embarrassment…
  • 2024 International Congress

    Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study

    H. Sarva, M. Tagliati, W. Poewe, F. Stocchi, O. Rascol, T. Yardeni, N. Lopes, J. Pereira, A. Espay (New York, USA)

    Objective: Evaluate quality of life (QoL) data from the Phase 3 randomized, active-controlled BouNDless study. Background: Pivotal data from the BouNDless study (NCT04006210) showed that…
  • 2024 International Congress

    Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

    R. Freeman, I. Biaggioni, R. Vickery, L. Norcliffe-Kaufmann, T. Guerin, M. Bryarly, V. Iodice, M. Rudzniska-Bar, M. Boczarska-Jedynak, C. Oehlwein, C. Shibao, H. Kaufmann (Boston, USA)

    Objective: To assess the long-term safety and tolerability of ampreloxetine in patients with synucleinopathies (MSA, PD, and PAF) and symptomatic neurogenic orthostatic hypotension (nOH) from…
  • 2024 International Congress

    Conceptualization of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) prototype.

    M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

    Objective: To outline the process of conceptualizing the prototype for the International Parkinson and Movement Disorder Society Parkinson's Disease Psychosis Rating Scale (MDS-PDPRS). Background: Approximately…
  • 2024 International Congress

    Gathering Prodromal Participant Perspective on Receiving Personal Research Information

    C. Destro, M. Mcguire Kuhl, J. Schulze, L. Heathers, T. Foroud, T. Tropea, B. Henry, J. Talarico, C. Stanley, E. Flagg (New York, USA)

    Objective: To understand perceptions and expectations of people with prodromal Parkinson’s disease (PD) around receiving personal research information. Background: There is limited information on the…
  • 2024 International Congress

    Health Care Utilization at the End-Of-Life in Parkinson´s Disease

    B. Leavy, E. åkesson, J. Lökk, T. Schultz, P. Strang, E. Franzén (Stockholm, Sweden)

    Objective: This study aims to increase knowledge concerning end of life health care utilization among an urban-dwelling Parkinson's disease (PD) cohort. More specifically we investigated frequency…
  • 2024 International Congress

    Acute effects of a multicomponent aquatic training session on heart rate variability in PD: a case study

    A. Doliny, S. Souza, J. Siega, V. Israel (CURITIBA, Brazil)

    Objective: To analyze the acute effects of a multicompartment aquatic training (MAT) session on heart rate variability (HRV) in a person with Parkinson's disease (PD).…
  • 2024 International Congress

    Uncovering Patient Perspectives on Parkinson’s Disease to Inform Individualized Care

    A. Di Rocco, M. Armstrong, J. Carter, C. Chadha, K. Olson, L. Simone, L. Jarzylo (New York, USA)

    Objective: To gather patient insights on the burden of Parkinson’s disease (PD), understand the level of patient involvement in treatment decision-making, and determine overall satisfaction…
  • 2024 International Congress

    Transforming Parkinson’s Care in Africa: Establishing the First Ever Support Group for People With Parkinson’s Disease and Their Caregivers in Tanzania.

    M. Shayo, K. Haukila, T. Park, R. Walker, N. Fothergill-Misbah (Moshi, United Republic of Tanzania)

    Objective: To establish a support group for people with Parkinson's disease (PwP) and caregivers in Tanzania as part of the Transforming Parkinson’s Care in Africa…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley